NeuBase Therapeutics Announces Gene Editing Research Agreement with Global Healthcare Company
Stock Information for NeuBase Therapeutics Inc.
Please wait while we load your information from QuoteMedia.
More Recent News About NeuBase Therapeutics Inc.
NeuBase Therapeutics Selected to Present Two Oral Presentations at the American Society of Gene & Cell Therapy (ASGCT) 2023 Annual Meeting
NeuBase Therapeutics Reports Business Update and Financial Results for the First Quarter of Fiscal Year 2023